Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diazepam
Drug ID BADD_D00648
Description A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589) Given diazepam's storied history as a commonly used and effective medication for a variety of indications, contemporary advancements in the formulation and administration of the agent include the development and US FDA approval of an auto-injectable formulation for the rapid treatment of uncontrolled seizures in 2015-2016 [L5200]. Combining diazepam, a proven effective therapy for acute repetitive seizures, with an auto-injector designed for subcutaneous administration that is quickly and easily administered offers the potential for complete, consistent drug absorption and rapid onset of effect [L5200]. This current development is subsequently an important addition to the rescue therapy tool chest for patients with epilepsy [L5200].
Indications and Usage Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.
Marketing Status Prescription; Discontinued
ATC Code N05BA01
DrugBank ID DB00829
KEGG ID D00293
MeSH ID D003975
PubChem ID 3016
TTD Drug ID D07JVL
NDC Product Code 0904-7117; 43063-970; 80425-0151; 70518-0162; 71872-7259; 52584-213; 68071-3330; 70518-1856; 70518-1270; 51862-943; 11014-0401; 68071-4899; 51862-942; 51862-941; 69339-136; 71610-427; 80425-0120; 71872-7260; 0140-0005; 69339-137; 67544-019; 0527-1767; 50090-3390; 0615-7800; 35356-812; 43353-278; 0378-0477; 61919-409; 11014-0400; 66490-650; 43353-281; 51079-286; 71554-118; 49452-2538; 63187-867; 68682-650; 67296-0291; 0409-1273; 71335-0444; 71610-460; 67296-0084; 12828-0013; 52584-273; 50090-4566; 45865-423; 63187-173; 58118-0640; 71610-424; 60760-934; 0527-1768; 0409-3213; 70518-2358; 0395-8143; 71610-270; 72252-510; 11014-0399; 55154-5074; 45865-482; 50090-1726; 68788-7452; 43353-825; 61919-906; 64330-010; 68071-4181; 51079-284; 0378-0345; 71610-459; 58118-4047; 61919-071; 68682-655; 68071-4770; 38779-0925; 63187-544; 68071-4829; 50090-0195; 0187-0659; 50090-2249; 45865-140; 11704-600; 71335-1584; 0378-0271; 48087-0005; 51927-0051; 72189-193; 0054-3188; 0641-6244; 63187-846; 53002-3340; 72252-520; 51552-1025; 0140-0006; 0140-0004; 58118-3926; 55289-092; 0172-3926; 70518-1713; 50090-1913; 0615-7799; 68682-652; 0121-0905; 63739-073; 80725-006; 63629-1523; 72252-515; 58118-3925; 43063-840; 55700-058; 51927-1014; 72252-505; 63629-2948; 60760-927; 43063-718; 48087-0112; 67544-020; 80725-004; 0172-3927; 55154-7885; 68071-3270; 0904-5880; 68071-4922; 80725-005; 0404-9848; 0187-0658; 50090-4713; 72572-140; 63629-7328; 49999-018; 68788-9207; 43063-987; 43353-276; 51079-285; 68094-750; 0172-3925; 70518-0014
Synonyms Diazepam | 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one | Diazemuls | Faustan | Valium | Seduxen | Sibazon | Stesolid | Apaurin | Relanium
Chemical Information
Molecular Formula C16H13ClN2O
CAS Registry Number 439-14-5
SMILES CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
AmnesiaTranslocator proteinP30536T754401352055; 10525757; 10428415; 10780255; 12845414; 8740046; 10884566; 7902274; 15501303; 10368858; 7913225; 2844992; 6147788; 11007074; 8234145
Anxiety disorderTranslocator proteinP30536T754401352055; 10525757; 10428415; 10780255; 12845414; 8740046; 10884566; 7902274; 15501303; 10368858; 7913225; 2844992; 6147788; 11007074; 8234145
SedationTranslocator proteinP30536T754401352055; 10525757; 10428415; 10780255; 12845414; 8740046; 10884566; 7902274; 15501303; 10368858; 7913225; 2844992; 6147788; 11007074; 8234145
SedationCytochrome P450 2C19P33261Not AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gamma-glutamyltransferase increased13.03.01.0110.000427%
Gastric haemorrhage24.07.02.007; 07.12.01.001--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised tonic-clonic seizure17.12.01.0020.001814%Not Available
Glomerular filtration rate decreased13.13.01.0090.000320%Not Available
Gynaecomastia05.05.02.003; 21.05.04.0030.000747%
Haematoma24.07.01.001--
Haemoglobin decreased13.01.05.003--Not Available
Haemoglobin increased13.01.05.0040.000320%
Haemorrhage intracranial17.08.01.008; 24.07.04.003--
Hallucination19.10.02.0020.002774%
Hallucination, auditory19.10.02.0030.000320%Not Available
Hallucination, visual19.10.02.0040.000534%Not Available
Hallucinations, mixed19.10.02.007--Not Available
Headache17.14.01.001--
Heart rate decreased13.14.04.0010.000111%Not Available
Heart rate increased13.14.04.002--Not Available
Heart rate irregular13.14.04.0030.000213%Not Available
Hepatic cirrhosis09.01.04.0010.000084%Not Available
Hepatic encephalopathy17.13.01.003; 09.01.03.0060.000213%Not Available
Hepatic failure09.01.03.002--
Hepatic function abnormal09.01.02.001--Not Available
Hepatic necrosis09.01.07.0020.000111%
Hepatic steatosis14.08.04.005; 09.01.07.0030.000167%Not Available
Hepatitis09.01.07.0040.000534%Not Available
Hepatitis acute09.01.07.0050.000747%Not Available
Hepatitis fulminant11.07.01.003; 09.01.07.0070.000960%Not Available
Hepatitis toxic12.03.01.016; 09.01.07.0170.000427%Not Available
Hepatocellular injury09.01.07.0080.002454%Not Available
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 21 Pages